Correlates of use of antifracture therapy in older women with low bone mineral density

Kathryn M. Ryder, Ronald I. Shorr, Frances Tylavsky, Andrew J. Bush, Douglas C. Bauer, Eleanor M. Simonsick, Elsa S. Strotmeyer, Tamara B. Harris

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND: Guidelines exist for treatment of low bone mineral density (BMD). Little is known about patient characteristics associated with use of treatment. OBJECTIVES: To determine patient-related correlates of medication use following screening dual x-ray absorptiometry (DXA) of older adults. DESIGN: Secondary analysis of a prospective cohort study. SETTING: Pittsburgh, PA and Memphis, TN. PARTICIPANTS: Community-dwelling women between the ages 70 and 79 years enrolled in the Health, Aging, and Body Composition (Health ABC) Study. MEASUREMENTS: Risk factors for fracture and BMD of the hip were assessed at baseline. Patients and their community physicians were supplied the results of the DXA scan. Prescription and over-the-counter medication use was collected at annual exams for 2 years. RESULTS: Of 1,584 women enrolled in Health ABC, 378 had an indication for antifracture therapy and were not receiving such treatment at baseline. By the second annual follow-up examination, prescription antiresorptive medication was reported in 49 (13.0%), whereas 65 (17.2%) received calcium and/or vitamin D supplementation. In adjusted models, the strongest predictor for use of any antifracture medicine was presence of osteoporosis [vs osteopenia, odds ratio (OR), 2.9 (1.7 to 4.7)], white race [OR, 2.6 (1.5 to 4.8)], and receipt of the flu shot [OR, 2.2 (1.3 to 3.8)]. Neither a history of falls nor prior fracture was associated with use of antifracture medications. CONCLUSION: Even when physicians of study participants were provided with DXA scan results, 70% of older high-functioning women with an indication for therapy did not start or remain on an antifracture therapy. Substantial room for improvement exists in fracture prevention following a diagnosis of low BMD - especially among women with a history of falls, prior fractures, and among black women.

Original languageEnglish (US)
Pages (from-to)636-641
Number of pages6
JournalJournal of General Internal Medicine
Volume21
Issue number6
DOIs
StatePublished - Jun 1 2006

Fingerprint

Bone Density
Odds Ratio
X-Rays
Body Composition
Prescriptions
Therapeutics
Independent Living
Physicians
Metabolic Bone Diseases
Health
Vitamin D
Osteoporosis
Hip
Cohort Studies
Medicine
Prospective Studies
Guidelines
Calcium

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Correlates of use of antifracture therapy in older women with low bone mineral density. / Ryder, Kathryn M.; Shorr, Ronald I.; Tylavsky, Frances; Bush, Andrew J.; Bauer, Douglas C.; Simonsick, Eleanor M.; Strotmeyer, Elsa S.; Harris, Tamara B.

In: Journal of General Internal Medicine, Vol. 21, No. 6, 01.06.2006, p. 636-641.

Research output: Contribution to journalArticle

Ryder, KM, Shorr, RI, Tylavsky, F, Bush, AJ, Bauer, DC, Simonsick, EM, Strotmeyer, ES & Harris, TB 2006, 'Correlates of use of antifracture therapy in older women with low bone mineral density', Journal of General Internal Medicine, vol. 21, no. 6, pp. 636-641. https://doi.org/10.1111/j.1525-1497.2006.00468.x
Ryder, Kathryn M. ; Shorr, Ronald I. ; Tylavsky, Frances ; Bush, Andrew J. ; Bauer, Douglas C. ; Simonsick, Eleanor M. ; Strotmeyer, Elsa S. ; Harris, Tamara B. / Correlates of use of antifracture therapy in older women with low bone mineral density. In: Journal of General Internal Medicine. 2006 ; Vol. 21, No. 6. pp. 636-641.
@article{aa230831041a49f7b270d073ce256517,
title = "Correlates of use of antifracture therapy in older women with low bone mineral density",
abstract = "BACKGROUND: Guidelines exist for treatment of low bone mineral density (BMD). Little is known about patient characteristics associated with use of treatment. OBJECTIVES: To determine patient-related correlates of medication use following screening dual x-ray absorptiometry (DXA) of older adults. DESIGN: Secondary analysis of a prospective cohort study. SETTING: Pittsburgh, PA and Memphis, TN. PARTICIPANTS: Community-dwelling women between the ages 70 and 79 years enrolled in the Health, Aging, and Body Composition (Health ABC) Study. MEASUREMENTS: Risk factors for fracture and BMD of the hip were assessed at baseline. Patients and their community physicians were supplied the results of the DXA scan. Prescription and over-the-counter medication use was collected at annual exams for 2 years. RESULTS: Of 1,584 women enrolled in Health ABC, 378 had an indication for antifracture therapy and were not receiving such treatment at baseline. By the second annual follow-up examination, prescription antiresorptive medication was reported in 49 (13.0{\%}), whereas 65 (17.2{\%}) received calcium and/or vitamin D supplementation. In adjusted models, the strongest predictor for use of any antifracture medicine was presence of osteoporosis [vs osteopenia, odds ratio (OR), 2.9 (1.7 to 4.7)], white race [OR, 2.6 (1.5 to 4.8)], and receipt of the flu shot [OR, 2.2 (1.3 to 3.8)]. Neither a history of falls nor prior fracture was associated with use of antifracture medications. CONCLUSION: Even when physicians of study participants were provided with DXA scan results, 70{\%} of older high-functioning women with an indication for therapy did not start or remain on an antifracture therapy. Substantial room for improvement exists in fracture prevention following a diagnosis of low BMD - especially among women with a history of falls, prior fractures, and among black women.",
author = "Ryder, {Kathryn M.} and Shorr, {Ronald I.} and Frances Tylavsky and Bush, {Andrew J.} and Bauer, {Douglas C.} and Simonsick, {Eleanor M.} and Strotmeyer, {Elsa S.} and Harris, {Tamara B.}",
year = "2006",
month = "6",
day = "1",
doi = "10.1111/j.1525-1497.2006.00468.x",
language = "English (US)",
volume = "21",
pages = "636--641",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Correlates of use of antifracture therapy in older women with low bone mineral density

AU - Ryder, Kathryn M.

AU - Shorr, Ronald I.

AU - Tylavsky, Frances

AU - Bush, Andrew J.

AU - Bauer, Douglas C.

AU - Simonsick, Eleanor M.

AU - Strotmeyer, Elsa S.

AU - Harris, Tamara B.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - BACKGROUND: Guidelines exist for treatment of low bone mineral density (BMD). Little is known about patient characteristics associated with use of treatment. OBJECTIVES: To determine patient-related correlates of medication use following screening dual x-ray absorptiometry (DXA) of older adults. DESIGN: Secondary analysis of a prospective cohort study. SETTING: Pittsburgh, PA and Memphis, TN. PARTICIPANTS: Community-dwelling women between the ages 70 and 79 years enrolled in the Health, Aging, and Body Composition (Health ABC) Study. MEASUREMENTS: Risk factors for fracture and BMD of the hip were assessed at baseline. Patients and their community physicians were supplied the results of the DXA scan. Prescription and over-the-counter medication use was collected at annual exams for 2 years. RESULTS: Of 1,584 women enrolled in Health ABC, 378 had an indication for antifracture therapy and were not receiving such treatment at baseline. By the second annual follow-up examination, prescription antiresorptive medication was reported in 49 (13.0%), whereas 65 (17.2%) received calcium and/or vitamin D supplementation. In adjusted models, the strongest predictor for use of any antifracture medicine was presence of osteoporosis [vs osteopenia, odds ratio (OR), 2.9 (1.7 to 4.7)], white race [OR, 2.6 (1.5 to 4.8)], and receipt of the flu shot [OR, 2.2 (1.3 to 3.8)]. Neither a history of falls nor prior fracture was associated with use of antifracture medications. CONCLUSION: Even when physicians of study participants were provided with DXA scan results, 70% of older high-functioning women with an indication for therapy did not start or remain on an antifracture therapy. Substantial room for improvement exists in fracture prevention following a diagnosis of low BMD - especially among women with a history of falls, prior fractures, and among black women.

AB - BACKGROUND: Guidelines exist for treatment of low bone mineral density (BMD). Little is known about patient characteristics associated with use of treatment. OBJECTIVES: To determine patient-related correlates of medication use following screening dual x-ray absorptiometry (DXA) of older adults. DESIGN: Secondary analysis of a prospective cohort study. SETTING: Pittsburgh, PA and Memphis, TN. PARTICIPANTS: Community-dwelling women between the ages 70 and 79 years enrolled in the Health, Aging, and Body Composition (Health ABC) Study. MEASUREMENTS: Risk factors for fracture and BMD of the hip were assessed at baseline. Patients and their community physicians were supplied the results of the DXA scan. Prescription and over-the-counter medication use was collected at annual exams for 2 years. RESULTS: Of 1,584 women enrolled in Health ABC, 378 had an indication for antifracture therapy and were not receiving such treatment at baseline. By the second annual follow-up examination, prescription antiresorptive medication was reported in 49 (13.0%), whereas 65 (17.2%) received calcium and/or vitamin D supplementation. In adjusted models, the strongest predictor for use of any antifracture medicine was presence of osteoporosis [vs osteopenia, odds ratio (OR), 2.9 (1.7 to 4.7)], white race [OR, 2.6 (1.5 to 4.8)], and receipt of the flu shot [OR, 2.2 (1.3 to 3.8)]. Neither a history of falls nor prior fracture was associated with use of antifracture medications. CONCLUSION: Even when physicians of study participants were provided with DXA scan results, 70% of older high-functioning women with an indication for therapy did not start or remain on an antifracture therapy. Substantial room for improvement exists in fracture prevention following a diagnosis of low BMD - especially among women with a history of falls, prior fractures, and among black women.

UR - http://www.scopus.com/inward/record.url?scp=33744483395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744483395&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1497.2006.00468.x

DO - 10.1111/j.1525-1497.2006.00468.x

M3 - Article

C2 - 16808749

AN - SCOPUS:33744483395

VL - 21

SP - 636

EP - 641

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 6

ER -